GNBT

Generex Biotechnology Corp.

 
Common Stock SEC Reporting - Current
Pink Current Information
Contact Info
  • 4145 North Service Road
  • Suite 200
  • Burlington, ONT L7L 6A3
  • Canada

Business Description


Update Company Profile
 
Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Oct 31, 2016 10-Q
CIK 0001059784
Fiscal Year End 7/31
OTC Marketplace Pink Current
Profile Data
SIC - Industry Classification 2834 - Pharmaceutical preparations
Incorporated In: DE, USA
Year of Inc. 1997
Employees 7 a/o Dec 01, 2015
Company Officers/Contacts
Mark Fletcher CEO, President
Eric H. von Hofe President
David Brusegard COO
Stephen Fellows CFO
Todd Falls Corp. Mktg. & IR Manager
Company Directors
Mark Fletcher
Eric H. von Hofe
Service Providers
Accounting/Auditing Firm
MNP LLP
900- 50 Burnhamthorpe Road West
Sussex Centre
Mississauga, ONT, L5B3C2
Canada
 
Securities Counsel
Eckert Seamans Cherin & Mellott, LLC
600 Grant Street
44th Floor
Pittsburgh, PA, 15219
United States
 
Investor Relations Firm

Not Available
Company History
  • Note=4-99 State of Incorporation Idaho changed to Delaware
  • Formerly=Green Mt P.S. Inc. until 1-98
GNBT Security Details
Share Structure
Market Value1 $13,900,685 a/o Feb 22, 2017
Authorized Shares 2,450,000,000 a/o Mar 31, 2016
Outstanding Shares 908,541,475 a/o Dec 29, 2016
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float Not Available
Par Value 0.001
Shareholders
Shareholders of Record 345 a/o Jan 20, 2017
Short Selling Data
Short Interest 616,737 (164.01%)
Jan 31, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security